Mount Sinai, Icahn School of Medicine — New York, New York

Mount Sinai, Icahn School of Medicine is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai, Icahn School of Medicine has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Paroxysmal Atrial Fibrillation, Inflammatory Bowel Diseases, Crohn's Disease.

Sponsors: Boston Scientific Corporation, Target PharmaSolutions, Inc., NeoChord.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai, Icahn School of Medicine?

Mount Sinai, Icahn School of Medicine has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai, Icahn School of Medicine conducted?

Mount Sinai, Icahn School of Medicine has 5 clinical trials on record, with 3 currently active. Their work covers Paroxysmal Atrial Fibrillation, Inflammatory Bowel Diseases, Crohn's Disease.

Is Mount Sinai, Icahn School of Medicine accredited by Crixeo Health?

Yes — Mount Sinai, Icahn School of Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mount Sinai, Icahn School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.